Cargando…

MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD

Age-related macular degeneration (AMD) is a leading cause of blindness worldwide affecting individuals over the age of 50. The neovascular form (NV AMD) is characterized by choroidal neovascularization (CNV) and responsible for the majority of central vision impairment. Using non-biased microRNA arr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ménard, Catherine, Rezende, Flavio A., Miloudi, Khalil, Wilson, Ariel, Tétreault, Nicolas, Hardy, Pierre, SanGiovanni, John Paul, De Guire, Vincent, Sapieha, Przemyslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991373/
https://www.ncbi.nlm.nih.gov/pubmed/27015561
http://dx.doi.org/10.18632/oncotarget.8280
_version_ 1782448844224593920
author Ménard, Catherine
Rezende, Flavio A.
Miloudi, Khalil
Wilson, Ariel
Tétreault, Nicolas
Hardy, Pierre
SanGiovanni, John Paul
De Guire, Vincent
Sapieha, Przemyslaw
author_facet Ménard, Catherine
Rezende, Flavio A.
Miloudi, Khalil
Wilson, Ariel
Tétreault, Nicolas
Hardy, Pierre
SanGiovanni, John Paul
De Guire, Vincent
Sapieha, Przemyslaw
author_sort Ménard, Catherine
collection PubMed
description Age-related macular degeneration (AMD) is a leading cause of blindness worldwide affecting individuals over the age of 50. The neovascular form (NV AMD) is characterized by choroidal neovascularization (CNV) and responsible for the majority of central vision impairment. Using non-biased microRNA arrays and individual TaqMan qPCRs, we profiled miRNAs in the vitreous humour and plasma of patients with NV AMD. We identified a disease-associated increase in miR-146a and a decrease in miR-106b and miR-152 in the vitreous humour which was reproducible in plasma. Moreover, miR-146a/miR-106b ratios discriminated patients with NV AMD with an area under the Receiver Operating Characteristic curve (ROC AUC) of 0,977 in vitreous humour and 0,915 in plasma suggesting potential for a blood-based diagnostic. Furthermore, using the AMD Gene Consortium (AGC) we mapped a NV AMD-associated SNP (rs1063320) in a binding site for miR-152-3p in the HLA-G gene. The relationship between our detected miRNAs and NV AMD related genes was also investigated using gene sets derived from the Ingenuity Pathway Analysis (IPA). To our knowledge, our study is the first to correlate vitreal and plasma miRNA signatures with NV AMD, highlighting potential future worth as biomarkers and providing insight on NV AMD pathogenesis.
format Online
Article
Text
id pubmed-4991373
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49913732016-09-01 MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD Ménard, Catherine Rezende, Flavio A. Miloudi, Khalil Wilson, Ariel Tétreault, Nicolas Hardy, Pierre SanGiovanni, John Paul De Guire, Vincent Sapieha, Przemyslaw Oncotarget Research Paper: Gerotarget (Focus on Aging) Age-related macular degeneration (AMD) is a leading cause of blindness worldwide affecting individuals over the age of 50. The neovascular form (NV AMD) is characterized by choroidal neovascularization (CNV) and responsible for the majority of central vision impairment. Using non-biased microRNA arrays and individual TaqMan qPCRs, we profiled miRNAs in the vitreous humour and plasma of patients with NV AMD. We identified a disease-associated increase in miR-146a and a decrease in miR-106b and miR-152 in the vitreous humour which was reproducible in plasma. Moreover, miR-146a/miR-106b ratios discriminated patients with NV AMD with an area under the Receiver Operating Characteristic curve (ROC AUC) of 0,977 in vitreous humour and 0,915 in plasma suggesting potential for a blood-based diagnostic. Furthermore, using the AMD Gene Consortium (AGC) we mapped a NV AMD-associated SNP (rs1063320) in a binding site for miR-152-3p in the HLA-G gene. The relationship between our detected miRNAs and NV AMD related genes was also investigated using gene sets derived from the Ingenuity Pathway Analysis (IPA). To our knowledge, our study is the first to correlate vitreal and plasma miRNA signatures with NV AMD, highlighting potential future worth as biomarkers and providing insight on NV AMD pathogenesis. Impact Journals LLC 2016-03-22 /pmc/articles/PMC4991373/ /pubmed/27015561 http://dx.doi.org/10.18632/oncotarget.8280 Text en Copyright: © 2016 Ménard et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Gerotarget (Focus on Aging)
Ménard, Catherine
Rezende, Flavio A.
Miloudi, Khalil
Wilson, Ariel
Tétreault, Nicolas
Hardy, Pierre
SanGiovanni, John Paul
De Guire, Vincent
Sapieha, Przemyslaw
MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title_full MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title_fullStr MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title_full_unstemmed MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title_short MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
title_sort microrna signatures in vitreous humour and plasma of patients with exudative amd
topic Research Paper: Gerotarget (Focus on Aging)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991373/
https://www.ncbi.nlm.nih.gov/pubmed/27015561
http://dx.doi.org/10.18632/oncotarget.8280
work_keys_str_mv AT menardcatherine micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT rezendeflavioa micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT miloudikhalil micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT wilsonariel micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT tetreaultnicolas micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT hardypierre micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT sangiovannijohnpaul micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT deguirevincent micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd
AT sapiehaprzemyslaw micrornasignaturesinvitreoushumourandplasmaofpatientswithexudativeamd